Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
812.00    2.00 (0.25%)
Bid:
814.00
Ask:
818.00
Spread: 4.00 (0.491%)
Market Cap: £374.30m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM Trading Update

14 Apr 2026 07:00

RNS Number : 2840A
Porvair PLC
14 April 2026
 

14 April 2026

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

AGM Trading Update

Group trading remains in line with our full year expectations. Integration of Drache acquisition remains on track.

Porvair plc ("Porvair" or the "Group"), the specialist filtration, laboratory and environmental technology group, will make the following trading statement at its Annual General Meeting to be held at 11.00 am today:

Four-month trading summary for the period to 31 March 2026

The Group has performed in line with expectations in the first four months of the year, delivering constant currency revenue growth of 5%. This performance reflects the qualities of Porvair's diversified portfolio, as market conditions remain varied across the Group's end markets.

Aerospace & Industrial

Aerospace order books remain strong, noting that the timing of delivery can be affected by changes in customer scheduling. Robust nuclear demand in the second half of 2025 has continued into the current year. Petrochemical sales, which can be lumpy, are lower compared with a strong prior period, and conditions in the European petrochemical market are expected to remain subdued throughout 2026.

Laboratory

Within life sciences, consumables order patterns remain steady, while environmental demand for instruments is in line with the prior year. New product introductions across life sciences and environmental are progressing as planned.

Metal Melt Quality

Aluminium and superalloys demand remains firm, whilst the auto, truck and agriculture end-markets, which represent a smaller part of the Group, remain subdued. There has been good progress with the new £5.5m aluminium cast house manufacturing line in Hendersonville, US, which remains on track for commissioning in the first half of 2026. The integration of Drache, acquired on 12 January 2026, is progressing well after three months with the Group and trading is consistent with the pre-acquisition investment case.

Outlook

The Board is closely monitoring the situation in the Middle East, in terms of both macro uncertainty and rising input prices. The Group's manufacturing footprint mainly serves local customers, and its decentralised management structure provides flexibility, agility and resilience in navigating volatile trading conditions, enabling key commercial decisions to be made closer to customers and suppliers.

The Board's expectations of the Group's full year performance remain unchanged, supported by a diversified customer base, strong recurring revenue streams and disciplined operational management. An increased focus on identifying M&A targets has surfaced some interesting prospects which are currently being evaluated. The Board sees no change in the Group's long-term strategic outlook or global growth drivers.

Capital Markets Event

Further to the full year results announcement, Porvair will host a Capital Markets Event in London on Thursday, 15 October 2026. Further details will be provided in due course.

Notice of results

The Group will announce its interim results for the six months ending 31 May 2026 on Monday 29 June 2026.

 

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

James Mills, Group Finance Director

 

Alma Strategic Communications

+44 (0)20 3405 0205

Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty

 

 

LEI: 213800ECKHS8LAQO3C45

 

Notes to editors

Porvair is a group of specialist filtration, laboratory and environmental technology companies. Our businesses design and manufacture bespoke consumable filtration products that are used in a range of niche markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEAFLDFASKEAA
Date   Source Headline
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration
9th Dec 20217:00 amRNSPre-close trading update and Notice of Results
23rd Nov 202112:30 pmRNSHolding(s) in Company
5th Nov 20214:40 pmRNSSecond Price Monitoring Extn
5th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:35 pmRNSPrice Monitoring Extension
16th Sep 20213:31 pmRNSDirector/PDMR Shareholding
14th Sep 20217:00 amRNSNine Month Trading Update
11th Aug 20214:41 pmRNSSecond Price Monitoring Extn
11th Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 20214:40 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20217:00 amRNSBlock listing Interim Review
5th Jul 20217:00 amRNSHalf Year Results 2021
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension
10th May 20214:40 pmRNSSecond Price Monitoring Extn
10th May 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20212:40 pmRNSGrant of LTSP awards
20th Apr 202112:30 pmRNSAGM resolutions and Board changes
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 20214:28 pmRNSTotal Voting Rights
17th Mar 20214:57 pmRNSHolding(s) in Company
16th Mar 20212:01 pmRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20213:27 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSAcquisition of Kbiosystems Limited
22nd Feb 20213:00 pmRNSHolding(s) in Company
19th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 20214:36 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSBlock listing Interim Review
8th Feb 20217:00 amRNSTotal Voting Rights
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
3rd Feb 20219:42 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSGrant of LTSP awards
1st Feb 20217:00 amRNSFinal Results
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:35 pmRNSPrice Monitoring Extension
30th Dec 20203:30 pmRNSHolding(s) in Company
30th Dec 20203:30 pmRNSHolding(s) in Company
9th Dec 20203:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.